Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Inclusion criteria: * Chronic HCV genotype 1 infection * No previous treatment for HCV infection * African American ethnicity * Serum HCV RNA ≥ 1000 IU/ml, assessed by quantitative polymerase chain reaction or equivalent at screening visit, no upper limit * A liver biopsy within 3 years prior to baseline Exclusion criteria: * HCV genotype different from genotype 1 or co-infection with other HCV genotype * Co-infection with Hepatitis B or HIV * Any other cause of relevant liver disease other than HCV * Presence or history of hepatic decompensation * Alanine aminotransferase (ALT) ≥ 10 times ULN, more than 1 episode of elevated bilirubin (\> ULN) in past 6 months Other protocol-defined inclusion/exclusion criteria may apply